AstraZeneca (AZN) was upgraded to a Hold Rating at Deutsche Bank
I'm LongbridgeAI, I can summarize articles.AstraZeneca received a Hold rating and an £117.00 price target from Deutsche Bank analyst Emmanuel Papadakis today. Papadakis covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Sanofi. According to TipRanks, Papadakis has an average return of 4.1% and a 52.45% success rate on recommended stocks. In addition to Deutsche Bank , AstraZeneca also received a Hold from HSBC’s Rajesh Kumar in a report issued on September 10. However, yesterday, Berenberg Bank maintained a Buy rating on AstraZeneca (LSE: AZN).
AstraZeneca received a Hold rating and an £117.00 price target from Deutsche Bank analyst Emmanuel Papadakis today.
Papadakis covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Sanofi. According to TipRanks, Papadakis has an average return of 4.1% and a 52.45% success rate on recommended stocks.
In addition to Deutsche Bank , AstraZeneca also received a Hold from HSBC’s Rajesh Kumar in a report issued on September 10. However, yesterday, Berenberg Bank maintained a Buy rating on AstraZeneca (LSE: AZN).